We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATO icon
2376
Cato Corp
CATO
$65.7M
$130K ﹤0.01%
+7,694
New +$114K
DZSI
2377
DELISTED
DZS Inc. Common Stock
DZSI
$130K ﹤0.01%
+6,251
New +$108K
LUNA
2378
DELISTED
Luna Innovations Incorporated
LUNA
$129K ﹤0.01%
11,906
+9,762
+455% +$106K
RES icon
2379
RPC Inc
RES
$1.4B
$129K ﹤0.01%
+26,045
New +$140K
YELL
2380
DELISTED
Yellow Corporation Common Stock
YELL
$128K ﹤0.01%
+19,682
New +$146K
FPI
2381
Farmland Partners
FPI
$425M
$127K ﹤0.01%
+10,577
New +$136K
ALT icon
2382
Altimmune
ALT
$570M
$126K ﹤0.01%
+12,799
New +$175K
FLL icon
2383
Full House Resorts
FLL
$83.5M
$126K ﹤0.01%
+12,675
New +$123K
CVM icon
2384
CEL-SCI Corp
CVM
$25.9M
$126K ﹤0.01%
483
EMKR
2385
DELISTED
Emcore Corp
EMKR
$125K ﹤0.01%
+1,358
New +$110K
DSPG
2386
DELISTED
DSP Group Inc
DSPG
$125K ﹤0.01%
8,441
+7,156
+557% +$107K
AKBA icon
2387
Akebia Therapeutics
AKBA
$248M
$123K ﹤0.01%
32,481
-28,415
-47% -$95.6K
CMRE icon
2388
Costamare
CMRE
$1.71B
$123K ﹤0.01%
10,419
-9,672
-48% -$104K
DSSI
2389
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$121K ﹤0.01%
+12,193
New +$126K
NPKI
2390
NPK International
NPKI
$1.19B
$120K ﹤0.01%
+34,631
New +$118K
PRLD icon
2391
Prelude Therapeutics
PRLD
$456M
$119K ﹤0.01%
4,148
AVNW icon
2392
Aviat Networks
AVNW
$282M
$118K ﹤0.01%
+3,608
New +$126K
SPPI
2393
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$116K ﹤0.01%
30,820
-29,620
-49% -$103K
REPX icon
2394
Riley Exploration Permian
REPX
$796M
$114K ﹤0.01%
+3,944
New +$141K
XONE
2395
DELISTED
The ExOne Company
XONE
$114K ﹤0.01%
5,260
FSP
2396
Franklin Street Properties
FSP
$46.3M
$114K ﹤0.01%
21,587
-21,517
-50% -$115K
TCRT icon
2397
Alaunos Therapeutics
TCRT
$4.88M
$113K ﹤0.01%
286
-283
-50% -$132K
TRUE
2398
DELISTED
TrueCar
TRUE
$113K ﹤0.01%
19,944
-20,408
-51% -$103K
CIO
2399
DELISTED
City Office REIT
CIO
$112K ﹤0.01%
9,005
-9,540
-51% -$110K
MBI icon
2400
MBIA
MBI
$254M
$111K ﹤0.01%
10,097
-11,174
-53% -$111K

Similar funds

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.